BioSpace News Archive

Quanterix Corporation announced that it will release its financial results for fourth quarter 2019 after the close of trading on Monday, March 9, 2020.

ST. LOUIS , Feb. 21, 2020 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today it will present at the Barclays Global Healthcare Conference, to be held at the Loews Miami Beach Hotel, March 10-12, 2020 . Centene will present on Tuesday, March 10 , at 8:00 a.m. Eastern Daylight Time (EDT). A simultaneous live audio webcast is available at: https://event.webca

Adrenomed AG, the vascular integrity company, today reported positive top-line results from its proof-of-concept AdrenOSS-2 Phase II trial.

IRVINE, Calif. , Feb. 21, 2020 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced a new goal for its philanthropic initiative, Every Heartbeat Matters (EHM): to improve the lives of 2.5 million additional underserved structural heart and crit

Feb. 21, 2020 13:30 UTC PARSIPPANY, N.J.--( BUSINESS WIRE )-- Zoetis Inc. (NYSE:ZTS) will participate in the Cowen and Company 40th Annual Health Care Conference on Monday, March 2, 2020, in Boston, Mass. Kristin Peck, Chief Executive Officer, will represent the company and respond to questions from analysts. She is scheduled to present at 2:10 p.m. ET. Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http:/

Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell joint replacement implants and instruments that are individually sized and shaped, and which the company refers to as personalized or individualized, to fit each patient’s unique anatomy, announced today that management will present at the Cowen 40th Annual Health Care Conference in Boston.

The AKC Canine Health Foundation celebrates its 25th anniversary in 2020.

Data will be presented on new and upcoming technologies, including a range of RNA depletion solutions, new Enzymatic Methyl-seq (EM-seq™) applications, new technologies for long-read sequencing applications and updates for RNA-seq workflows, including UMIs (Unique Molecular Indices).

Feb. 21, 2020 15:32 UTC BEIJING--( BUSINESS WIRE )-- Genetron Holding Limited (“ Genetron Health ”), a China-based precision oncology company that covers full-cycle cancer care, has announced a strategic partnership with Beijing InnoCare Pharma Tech Co., Ltd. (“ InnoCare ”) to provide clinical trial genomic testing and companion diagnostics development services for InnoCare’s biomarker-driven oncology drug development. Committed to advancing the research and development proce

OSLO, Norway , Feb. 21, 2020 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) announces that it will report its results for the fourth quarter and full year 2019 on Thursday, 27 February 2020. A presentation by Nordic Nanovector’s senior management team will take place at 8:30am CET at: Thon Hotel Vika Atrium, Munkedamsveien 45, 0250 Oslo Meeting Room: VIPPETANGEN